Cardiac electrophysiological effects of propafenone and its 5-hydroxylated metabolite in the conscious dog
- 14 November 1996
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 315 (2) , 171-177
- https://doi.org/10.1016/s0014-2999(96)00624-3
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Chronotropic cardiac effects of NPY in conscious dogs: interactions with the autonomic nervous system and putative NPY receptorsRegulatory Peptides, 1994
- Chronotropic Cardiac Effects of Falipamil in Conscious Dogs: Interactions with the Autonomic Nervous System and Various Ionic ConductancesJournal of Cardiovascular Pharmacology, 1994
- Acute and Long-Term Efficacy of Oral Propafenone in Patients with Ventricular TachyarrhythmiasJournal of Cardiovascular Pharmacology, 1991
- Developmental Electrophysiologic Effects of Propafenone and 5-Hydroxypropafenone on the Canine Cardiac Purkinje FiberDevelopmental Pharmacology and Therapeutics, 1991
- Influence of Pentobarbital and Chloralose Anesthesia on Quinidine-Induced Effects on Atrial Refractoriness and Heart Rate in the DogJournal of Cardiovascular Pharmacology, 1991
- Propafenone versus amiodarone in field treatment of primary atrial tachydysrhythmiasThe Journal of Emergency Medicine, 1990
- Methods for producing experimental complete atrioventricular block in dogsJournal of Pharmacological Methods, 1985
- Clinical efficacy and electrophysiology of oral propafenone for ventricular tachycardiaThe American Journal of Cardiology, 1983
- A comparison of changes in atropine-induced tachycardia and atropine concentration in consciuos dogsEuropean Journal of Pharmacology, 1979
- Propafenon und Lidoflazin bei chronischem Vorhofflimmern und -flatternDeutsche Medizinische Wochenschrift (1946), 1978